Affinity DataKi: 0.260nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
Affinity DataKi: 0.350nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
Affinity DataKi: 0.380nMAssay Description:Inhibition of CK2alpha (unknown origin) using RRRADDSDDDDD as substrate in presence of [gamma33P]-ATP by autoradiographyMore data for this Ligand-Target Pair
Affinity DataKi: 1.90nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
Affinity DataKi: 5nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
Affinity DataKi: 5nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
Affinity DataKi: 7nMAssay Description:Inhibition of CK2alpha (unknown origin)More data for this Ligand-Target Pair
Affinity DataKi: 7nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
Affinity DataKi: 8nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
Affinity DataKi: 8nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
Affinity DataKi: 9nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
Affinity DataKi: 11nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
Affinity DataKi: 11nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
Affinity DataKi: 12nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
Affinity DataKi: 13nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
Affinity DataKi: 13nMAssay Description:Inhibition of human CK2 alpha catalytic subunit expressed in Escherichia coli BL21 (DE3) assessed as [33P]gamma-ATP incorporation into RRRADDSDDDDD s...More data for this Ligand-Target Pair
Affinity DataKi: 14nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
Affinity DataKi: 15nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
Affinity DataKi: 17nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
Affinity DataKi: 20nMAssay Description:Inhibition of CK2alpha (unknown origin)More data for this Ligand-Target Pair
Affinity DataKi: 23nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
Affinity DataKi: 24nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
Affinity DataKi: 32nMAssay Description:Inhibition of CK2alpha (unknown origin) using RRRADDSDDDDD as substrate in presence of [gamma33P]-ATP by autoradiographyMore data for this Ligand-Target Pair
Affinity DataKi: 35nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
Affinity DataKi: 40nMAssay Description:Binding affinity to CK2alpha (unknown origin)More data for this Ligand-Target Pair
Affinity DataKi: 40nMAssay Description:Inhibition of CK2alpha in human PLC1 cells using (Arg)3(Glu)3Thr(Glu)3 as substrate after 24 hrs in presence of [32P]gammaGTPMore data for this Ligand-Target Pair
Affinity DataKi: 43nMAssay Description:Inhibition of human CK2 alpha catalytic subunit expressed in Escherichia coli BL21 (DE3) assessed as [33P]gamma-ATP incorporation into RRRADDSDDDDD s...More data for this Ligand-Target Pair
Affinity DataKi: 45nMAssay Description:Inhibition of human wild type CK2alphaMore data for this Ligand-Target Pair
Affinity DataKi: 45nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
Affinity DataKi: 55nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
Affinity DataKi: 60nMAssay Description:Inhibition of CK2alpha (unknown origin)More data for this Ligand-Target Pair
Affinity DataKi: 60nMAssay Description:Inhibition of CK2alpha (unknown origin)More data for this Ligand-Target Pair
Affinity DataKi: 70nMAssay Description:Inhibition of human wild type CK2alphaMore data for this Ligand-Target Pair
Affinity DataKi: 77nMAssay Description:Inhibition of CK2alpha (unknown origin) using RRRADDSDDDDD as substrate in presence of [gamma33P]-ATP by autoradiographyMore data for this Ligand-Target Pair
Affinity DataKi: 77nMAssay Description:Inhibition of human CK2 alpha catalytic subunit expressed in Escherichia coli BE21 (DE3) assessed as [33P]gamma-ATP incorporation into P2B substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 80nMAssay Description:Inhibition of human CK2 alpha catalytic subunit expressed in Escherichia coli BL21 (DE3) assessed as [33P]gamma-ATP incorporation into RRRADDSDDDDD s...More data for this Ligand-Target Pair
Affinity DataKi: 83nMAssay Description:Inhibition of human CK2 alpha catalytic subunit expressed in Escherichia coli BL21 (DE3) assessed as [33P]gamma-ATP incorporation into RRRADDSDDDDD s...More data for this Ligand-Target Pair
Affinity DataKi: 88nMAssay Description:Inhibition of human CK2 alpha catalytic subunit expressed in Escherichia coli BE21 (DE3) assessed as [33P]gamma-ATP incorporation into P2B substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 88nMAssay Description:Inhibition of human CK2 alpha catalytic subunit expressed in Escherichia coli BE21 (DE3) assessed as [33P]gamma-ATP incorporation into P2B substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 95nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
Affinity DataKi: 97nMAssay Description:Inhibition of human CK2 alpha catalytic subunit expressed in Escherichia coli BE21 (DE3) assessed as [33P]gamma-ATP incorporation into P2B substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 106nMAssay Description:Inhibition of human CK2 alpha catalytic subunit expressed in Escherichia coli BE21 (DE3) assessed as [33P]gamma-ATP incorporation into P2B substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 110nMAssay Description:Inhibition of human CK2 alpha catalytic subunit expressed in Escherichia coli BE21 (DE3) assessed as [33P]gamma-ATP incorporation into P2B substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 112nMAssay Description:Inhibition of human CK2 alpha catalytic subunit expressed in Escherichia coli BE21 (DE3) assessed as [33P]gamma-ATP incorporation into P2B substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 116nMAssay Description:Inhibition of human CK2 alpha catalytic subunit expressed in Escherichia coli BE21 (DE3) assessed as [33P]gamma-ATP incorporation into P2B substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 126nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
Affinity DataKi: 137nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
Affinity DataKi: 137nMAssay Description:Inhibition of human CK2 alphaMore data for this Ligand-Target Pair
Affinity DataKi: 137nMAssay Description:Inhibition of human CK2 alpha catalytic subunit expressed in Escherichia coli BL21 (DE3) assessed as [33P]gamma-ATP incorporation into RRRADDSDDDDD s...More data for this Ligand-Target Pair
Affinity DataKi: 139nMAssay Description:Inhibition of human CK2 alpha catalytic subunit expressed in Escherichia coli BL21 (DE3) assessed as [33P]gamma-ATP incorporation into RRRADDSDDDDD s...More data for this Ligand-Target Pair